How is the role of the pharmacist changing as treatments in hematological cancers develop? Susannah Koontz Webb, PharmD, BCOP, FHOP, President of the Hematology Oncology Pharmacy Association (HOPA) discusses the treatment advances in blood cancers, and how the movement towards more targeted therapies means that patients can received tailored treatments and can receive more medications in an outpatient setting. These developments create new roles and challenges for pharmacists, making it an exciting time in the field. This interview was recorded at the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK.
This video has been supported by Napp Pharmaceuticals Ltd through an unrestricted educational grant to Magdalen Medical Publishing.
Changing treatment landscapes, new challenges for hemonc pharmacists
